2 items from 2016
Exclusive: The companies have struck a world sales alliance on Yuji Shimomura’s completed action title in the run-up to Busan and Afm.
Nikkatsu Corporation will handle international sales on Re:Born while Xyz Films represents North American rights.
Star Tak Sakaguchi reunites with his director of Versus and Death Trance in the story about a retired special forces soldier who comes out of retirement when his niece is kidnapped by his former employer.
“It may sound bold, but Re:Born could be the new cornerstone in action movies,” said Inoue. “Tak Sakaguchi and the director Yuji Shimomura have put their blood and sweat together for the last five years during which Tak gave up the whole concept of so-called entertainment action but instead trained to adjust himself to the most practical combat techniques.
“On the other »
- email@example.com (Jeremy Kay)
Japanese action star Tak Sakiguchi makes a welcome return to the screen in this stripped-down action thriller that sees a deadly super soldier forced out of seclusion and back to his old ways of precision destruction. After a somewhat sluggish first act that insists on laying down unnecessary context and backstory, the action in Re: Born kicks into gear and never lets up, showcasing some brutal close-quarter combat to rival anything emerging from Asia right now. Director Yuji Shimomura has collaborated with Tak on numerous occasions, directing him in 2005’s Death Trance as well as serving as action director on Versus and Yakuza Weapon, in addition to working on big budget projects including Gantz: Perfect Answer and Library Wars. Together with acclaimed fight choreographer...
[Read the whole post on screenanarchy.com...] »
2 items from 2016
IMDb.com, Inc. takes no responsibility for the content or accuracy of the above news articles, Tweets, or blog posts. This content is published for the entertainment of our users only. The news articles, Tweets, and blog posts do not represent IMDb's opinions nor can we guarantee that the reporting therein is completely factual. Please visit the source responsible for the item in question to report any concerns you may have regarding content or accuracy.See our NewsDesk partners